ZH

RU

ES

regenerative medicine therapy

regenerative medicine therapy, Total:499 items.

In the international standard classification, regenerative medicine therapy involves: Vocabularies, Medical sciences and health care facilities in general, Medical equipment, Laboratory medicine, Sterilization and disinfection, Applications of information technology, Microbiology, Dentistry, Bottles. Pots. Jars, Information sciences. Publishing, Services, Company organization and management, Pharmaceutics, Animal feeding stuffs, Veterinary medicine, Software development and system documentation, Non-destructive testing, Water quality, Electromagnetic compatibility (EMC), Corrosion of metals, Iron and steel products, Protection against crime, HEALTH CARE TECHNOLOGY, Analytical chemistry, Wastes.


British Standards Institution (BSI), regenerative medicine therapy

  • BS PAS 84:2012 Cell therapy and regenerative medicine. Glossary
  • DD ISO/TS 10993-20:2006 Biological evaluation of medical devices. Principles and methods for immunotoxicology testing of medical devices
  • BS DD ISO/TS 10993-20:2006 Biological evaluation of medical devices - Principles and methods for immunotoxicology testing of medical devices
  • BS EN ISO 17664:2004 Sterilization of medical devices - Information to be provided by the manufacturer for the processing of resterilizable medical devices
  • PAS 84-2008 Regenerative medicine-- Glossary PUBLICLY AVAILABLE SPECIFICATION
  • PD 6610:1997 Medical informatics. Methodology for the development of healthcare messages
  • BS 5213:1975 Specification for medical specimen containers for microbiology
  • ISO 10993-18:2020/Amd.1:2022 Biological evaluation of medical devices - Chemical characterization of medical device materials within a risk management process
  • BS EN ISO 10993-18:2020+A1:2023 Biological evaluation of medical devices - Chemical characterization of medical device materials within a risk management process
  • BS DD CEN/TS 14463:2003 Health informatics - A syntax to represent the content of medical classification systems (CIaML)
  • PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • BS EN 16872:2016 Services of Medical Doctors with additional qualification in Homeopathy (MDQH). Requirements for health care provision by Medical Doctors with additional qualification in Homeopathy
  • BS PD ISO/TS 22077-5:2021 Health informatics. Medical waveform format. Neurophysiological signals
  • BS EN ISO 10993-2:2022 Biological evaluation of medical devices - Animal welfare requirements
  • 21/30379304 DC BS EN ISO 10993-17. Biological evaluation of medical devices - Part 17. Toxicological risk assessment of medical device constituents
  • BS EN ISO 10993-13:1999 Biological evaluation of medical devices - Identification and quantification of degradation products from polymeric medical devices
  • BS EN ISO 10993-13:2010 Biological evaluation of medical devices. Part 13: Identification and quantification of degradation products from polymeric medical devices
  • PD ISO/TR 10993-22:2017 Biological evaluation of medical devices. Guidance on nanomaterials
  • PD 6610-1997 Medical informatics. Methodology for the development of healthcare messages
  • BS PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • BS EN ISO 7405:2009 Dentistry. Evaluation of biocompatibility of medical devices used in dentistry
  • BS EN ISO 7405:2008 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry
  • PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • PD ISO/TS 22077-5:2021 Health informatics. Medical waveform format. Neurophysiological signals
  • BS EN 62563-1:2010+A2:2021 Medical electrical equipment. Medical image display systems - Evaluation methods
  • BS EN ISO 7405:2008+A1:2013 Dentistry. Evaluation of biocompatibility of medical devices used in dentistry
  • 18/30358832 DC BS EN ISO 10993-18. Biological evaluation of medical devices. Part 18. Chemical characterization of medical device materials within a risk management process
  • 21/30439273 DC BS EN ISO 10993-18 AMD1. Biological evaluation of medical devices - Part 18. Chemical characterization of medical device materials within a risk management process
  • BS EN ISO 10993-10:2002 Biological evaluation of medical devices - Tests for irritation and delayed-type hypersensitivity
  • BS EN ISO 10993-12:2007 Biological evaluation of medical devices - Sample preparation and reference materials
  • BS EN ISO 10993-7:2008 Biological evaluation of medical devices - Ethylene oxide sterilization residuals
  • BS EN ISO 10993-12:2004 Biological evaluation of medical devices - Sample preparation and reference materials
  • BS EN ISO 10993-12:2012 Biological evaluation of medical devices. Sample preparation and reference materials
  • 19/30363066 DC BS EN IEC 63120. Refurbishment of medical electrical equipment, medical electrical systems and sub-assemblies and reuse of components as part of the extended life-cycle
  • PD ISO/TS 10993-19:2020 Biological evaluation of medical devices. Physico-chemical, morphological and topographical characterization of materials
  • BS EN ISO 10993-11:2018 Biological evaluation of medical devices. Tests for systemic toxicity
  • BS EN ISO 10993-6:2009 Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-10:2010 Biological evaluation of medical devices. Tests for irritation and skin sensitization
  • BS EN ISO 10993-10:2023 Tracked changes. Biological evaluation of medical devices. Tests for skin sensitization
  • BS EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
  • BS EN ISO 10993-16:1997 Biological evaluation of medical devices - Toxicokinetic study design for degradation products and leachables
  • BS PD ISO/TR 15499:2016 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • BS EN ISO 10993-1:2009 Biological evaluation of medical devices - Evaluation and testing within a risk management process
  • BS EN ISO 10993-23:2021 Biological evaluation of medical devices. Evaluation and testing within a risk management process
  • PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • PD ISO/TR 10993-55:2023 Biological evaluation of medical devices. Interlaboratory study on cytotoxicity
  • DD ENV 13730-2:2002 Healthcare informatics. Blood transfusion related messages. Production related messages (BTR-PROD)
  • BS PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • BS EN ISO 10993-14:2009 Biological evaluation of medical devices - Identification and quantification of degradation products from ceramics
  • BS EN ISO 10993-17:2009 Biological evaluation of medical devices. Establishment of allowable limits for leachable substances
  • PD ISO/TR 15499:2016 Tracked Changes. Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • BS EN ISO 10993-7:2008+A1:2022 Tracked Changes. Biological evaluation of medical devices. Ethylene oxide sterilization residuals
  • BS EN ISO 10993-6:2016 Tracked Changes. Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-12:2021 Tracked Changes. Biological evaluation of medical devices. Sample preparation and reference materials

Professional Standard - Medicine, regenerative medicine therapy

  • YY/T 1912-2023 Biological evaluation and testing of medical devices for soft tissue regeneration
  • YY/T 1815-2022
  • YY/T 0127.12-2008 Dentistry.Biological evaluation of medical devices used in dentistry Part 2:Test method.Micronucleus test
  • YY/T 0127.4-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method Bone implant test
  • YY/T 0127.11-2014 Biological evaluation of medical devices used in dentistry.Part 11:Pulp capping test
  • YY/T 0268-2008 Dentistry.Biological evaluation of medical devices used in dentistry.Part 1:Evaluation and test
  • YY/T 1295-2015 Biological evaluation of medical devices.Nanomaterial: Endotoxin test
  • YY/T 0127.5-2014 Biological evaluation of medical devices used in dentistry.Part 5:Inhalation toxicity test
  • YY/T 0127.13-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method.Oral mucous membrane irritation test
  • YY/T 0127.3-2014 Biological evaluation of medical devices used in dentistry.Part 3: Endodontic usage test
  • YY/T 0127.14-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method.Acute oral toxicity test
  • YY/T 0606.10-2008 Tissue engineered medical product.Part 10: In vivo assessment of implantable devices intended torepair or regenerate articular cartilage

未注明发布机构, regenerative medicine therapy

American Society for Testing and Materials (ASTM), regenerative medicine therapy

  • ASTM F2150-19 Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products
  • ASTM F2900-11 Standard Guide for Characterization of Hydrogels used in Regenerative Medicine
  • ASTM E2314-03 Standard Test Method for Determination of Effectiveness of Cleaning Processes for Reusable Medical Instruments Using a Microbiologic Method (Simulated Use Test)
  • ASTM E2314-03(2008) Standard Test Method for Determination of Effectiveness of Cleaning Processes for Reusable Medical Instruments Using a Microbiologic Method (Simulated Use Test)
  • ASTM E1766-95(2007) Standard Test Method for Determination of Effectiveness of Sterilization Processes for Reusable Medical Devices
  • ASTM E1766-95 Standard Test Method for Determination of Effectiveness of Sterilization Processes for Reusable Medical Devices
  • ASTM E1766-95(2002) Standard Test Method for Determination of Effectiveness of Sterilization Processes for Reusable Medical Devices
  • ASTM F1329-00 Standard Guide for Training the Emergency Medical Technician (Basic) in Basic Anatomy and Physiology (Withdrawn 2006)

GOSTR, regenerative medicine therapy

  • GOST 34310-2017 Biological medicine remedies for veterinary use. Methods for determination of mertiolyt, phenol, formaldehyde
  • GOST R 52770-2020 Medical devices. Evaluation system of biological effects. Part 1. General requirements for biological safety
  • GOST ISO/TR 10993-22-2020 Medical devices. Biological evaluation of medical devices. Part 22. Guidance on nanomaterials
  • GOST 33871-2016 Biological medicine remedies for veterinary use. Vaccines against viral diseases of animals. Method of determination of activity
  • GOST ISO 10993-3-2018 Medical levices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicit
  • GOST ISO 10993-4-2020 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST R ISO 10993-2-2009 Standardization in the Russian Federation. Medical devices. Biological evaluation of medical devices. Part 2. Animal welfare requirements
  • GOST ISO/TR 10993-33-2018 Medical levices. Biological evaluation of medical devices. Part 33. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • GOST R EN 12322-2010 In vitro diagnostic medical devices. Culture media for microbiology. Performance criteria for culture media

RU-GOST R, regenerative medicine therapy

  • GOST ISO/TS 10993-20-2011 Medical devices. Biological evaluation of medical devices. Part 20. Principles and methods for immunotoxicology testing of medical devices
  • GOST ISO/TS 10993-19-2011 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials
  • GOST ISO 10993-18-2011 Medical devices. Biological evaluation of medical devices. Part 18. Chemical characterization of materials
  • GOST R 52770-2016 Medical devices. Safety requirements. Methods of sanitation-chemical and toxicological tests
  • GOST R 52770-2007 Medical products. Safety requirements. Methods of sanitation-chemical and toxicological tests
  • GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods
  • GOST ISO 10993-1-2011 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing
  • GOST ISO 10993-11-2011 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic toxicity
  • GOST R ISO 10993-11-1999 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic to xicity
  • GOST R ISO 10993-10-1999 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and sensitization
  • GOST ISO 10993-5-2011 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
  • GOST ISO 10993-7-2016 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-13-2011 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
  • GOST ISO 10993-13-2016 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
  • GOST R 55291-2012 Probiotic medicine remedies for veterinary use. Methods of microbiological analysis
  • GOST R ISO 10993.7-1999 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-6-2011 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST ISO 10993-12-2011 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and control materials
  • GOST ISO 10993-7-2011 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST R ISO 10993-6-1999 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST R ISO 10993-12-1999 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • GOST ISO 10993-3-2011 Medical devices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GOST 33275-2015 Biological medicine remedies for veterinary use. Vaccines fowl pox. Specifications
  • GOST ISO 11138-3-2012 Sterilization of health care products. Biological indicators. Part 3. Biological indicators for moist heat sterilization
  • GOST ISO 10993-10-2011 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and delayed-type hypersensitivity
  • GOST R ISO 10993.4-1999 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST ISO 10993-17-2011 Medical devices. Biological evaluation of medical devices. Part 17. Establishment of allowable limits for leachable substances
  • GOST ISO 10993-14-2011 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST ISO 10993-16-2016 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-4-2011 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST R ISO 10993-14-2001 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST ISO 11138-1-2012 Sterilization of health care products. Biological indicators. Part 1. Technical requirements
  • GOST R ISO 11138-1-2000 Sterilization of health care products. Biological indicators. Part 1. General requirements
  • GOST R ISO 10993.16-1999 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-16-2011 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 11138-2-2012 Sterilization of health care products. Biological indicators. Part 2. Biological indicators for ethylene oxide sterilization
  • GOST R ISO 11138-2-2000 Sterilization of health care products. Biological indicators. Part 2. Biological indicators for ethylene oxide sterilization
  • GOST ISO 10993-9-2011 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • GOST ISO 10993-9-2015 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • GOST R ISO 10993.13-1999 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices / Note: To be replaced by GOST R ISO 10993-13 (2009).
  • GOST R ISO 18472-2009 Sterilization of health care products. Biological and chemical indicators. Test equipment
  • GOST R 57647-2017 Medicines for medical applications. Pharmacogenomics. Biomarkers
  • GOST R ISO 10993.1-1999 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing / Note: To be replaced by GOST R ISO 10993-1 (2009).
  • GOST ISO 10993-15-2011 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
  • GOST R ISO 10993-15-2001 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
  • GOST R 55765-2013 Biological medicine remedies for vteterinary use. Vaccines against a virus hemorrhagic disease of rabbits tissue inactivated. Specifications
  • GOST ISO 10993-12-2015 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials

Korean Agency for Technology and Standards (KATS), regenerative medicine therapy

  • KS P ISO 10993-20-2009(2019) Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
  • KS P ISO 10993-20:2009 Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
  • KS P ISO 10993-18:2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process
  • KS P ISO 7405:2010 Dentistry-Evaluation of biocompatibility of medical devices used in dentistry
  • KS P ISO 7405:2014 Dentistry — Evaluation of biocompatibility of medical devices used in dentistry
  • KS P ISO 10993-18-2009(2019) Biological evaluation of medical devices-Part 18:Chemical characterization of materials
  • KS P ISO TS 20993-2009(2014) Biological evaluation of medical devices-Guidance on a risk-management process
  • KS P ISO 10993-18:2009 Biological evaluation of medical devices-Part 18:Chemical characterization of materials
  • KS P ISO 10993-13:2007 Biological evaluation of medical devices-Part 13:Identification and quantification of degradation products from polymeric medical devices
  • KS P ISO 10993-13:2018 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
  • KS P ISO 10993-1:2007 Biological evaluation of medical devices-Part 1:Evaluation and testing
  • KS P ISO 10993-1:2020 Biological evaluation of medical devices —Part 1: Evaluation and testing within a risk management process
  • KS P ISO 10993-2-2010(2021) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-11-2007(2017) Biological evaluation of medical devices-Part 11:Tests for systemic toxicity
  • KS P ISO 10993-2-2010(2016) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-2:2010 Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-5:2007 Biological evaluation of medical devices-Part 5:Tests for in vitro cytotoxicity
  • KS P ISO TR 10993-22:2020 Biological evaluation of medical devices —Part 22: Guidance on nanomaterials
  • KS P ISO 10993-11:2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS C IEC 62563-1:2019 Medical electrical equipment — Medical image display systems — Part 1: Evaluation methods
  • KS P ISO 10993-19:2009 Biological evaluation of medical devices-Part 19:Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-8:2002 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-8:2007 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-11:2007 Biological evaluation of medical devices-Part 11:Tests for systemic toxicity
  • KS P ISO TR 37137:2019 Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants
  • KS P ISO 10993-7:2017 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO 10993-5:2018 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
  • KS P ISO 10993-19-2009(2019) Biological evaluation of medical devices-Part 19:Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-7:2010 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO 10993-12:2007 Biological evaluation of medical devices-Part 12:Sample preparation and reference materials
  • KS P ISO 10993-6:2007 Biological evaluation of medical devices-Part 6:Tests for local effects after implantation
  • KS P ISO 10993-10:2018 Biological evaluation of medical devices — Part 10: Tests for irritation and skin sensitization
  • KS P ISO 10993-12-2014(2019) Biological evaluation of medical devices —Part 12: Sample preparation and reference materials
  • KS P ISO 10993-12:2014 Biological evaluation of medical devices — Part 12: Sample preparation and reference materials
  • KS P ISO TS 10993-19:2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials

General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China, regenerative medicine therapy

  • GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices
  • GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process
  • GB/T 16886.18-2011 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1: Evaluation and testing
  • GB/T 16886.13-2001 Biological evaluation of medical devices--Part 13:Identification and quantification of degradation products from polymeric medical devices
  • GB/T 19973.1-2015 Sterilization of medical devices.Microbiological methods.Part 1:Determination of a population of microorganisms on products
  • GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2: Animal welfare requirements
  • GB/T 16886.11-1997 Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
  • GB/Z 16886.22-2022 Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
  • GB/T 16886.11-2011 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • GB/T 19973.1-2023 Microbiological methods for sterilization of healthcare products - Part 1: Determination of the total number of microorganisms on products
  • GB/T 16886.10-2000 Biological evaluation of medical devices--Part 10: Tests for irritation and sensitization
  • GB/T 24628-2009 Sterilization of health care products.Biological and chemical indicators.Test equipment
  • GB/T 18732-2002 Determination of limits for industrial,scientific and medical equipment
  • GB/Z 18732-2002/GISPR 23-1987 Determination of limits for industrial,scientific and medical equipment(CISPR 23:1987,IDT)
  • GB/Z 18732-2002 Determination of limits for industrial,scientific and medical equipment (CISPR 23:1987,IDT)
  • GB/Z 18732-2002/GISPR 23:1987 Determination of limits for industrial,scientific and medical equipment(CISPR 23:1987,IDT)
  • GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests
  • GB/T 16886.5-2003 Biological evaluation of medical devices--Part 5: Test for in vitro cytotoxicity
  • GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
  • GB/T 16886.19-2011 Biological evaluation of medical devices.Part 19: Physico-chemical,morphological and topographical characterization of materials
  • GB/T 16886.12-2005 Biological evaluation of medical devices-Part 12:Sample preparation and reference materials
  • GB/T 16886.6-2015 Biological evaluation of medical devices.Part 6:Tests for local effects after implantation
  • GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals
  • GB/T 16886.12-2000 Biological evaluation of medical devices--Part 12: Sample preparation and reference materials
  • GB/T 16886.7-2001 Biological evaluation of medical devices--Part 7:Ethylene oxide sterilization residuals
  • GB/T 16886.6-1997 Biological evaluation of medical devices--Part 6: Tests for local effects after implantation
  • GB/T 16886.3-2008 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.3-1997 Biological evaluation of medical devices--Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 22597-2014 Determination of chemical oxygen demand of reclaimed wastewater.Potassium dichromate method
  • GB/T 22597-2008 Recalimed wastewater-Determination of chemical oxygen demand.Postassium dichromate method

Canadian Standards Association (CSA), regenerative medicine therapy

  • CSA SPE 1112-2014 Medical Device Reprocessing in Community Health Care Settings
  • CSA ISO-10993.2-97-CAN/CSA:1997 Evaluation Biologique Des Dispositifs Medicaux - Partie 2: Exigences Concernant La Protection Des Animaux
  • CSA ISO 10993.2-97-CAN/CSA:1997 Evaluation biologique des dispositifs medicaux - Partie 2: Exigences concernant la protection des an imaux La Premiere Edition; ISO 10993-2: 1992
  • CSA ISO 10993-13-00-CAN/CSA:2000 Biological Evaluation of Medical Devices - Part 13: Identification and Quantification of Degradation Products from Polymeric Medical Devices First Edition; ISO 10993-13: 1998

Shanghai Provincial Standard of the People's Republic of China, regenerative medicine therapy

  • DB31/T 60.1-1991 Basic Requirements for Medical Inspection Report Form
  • DB31/T 60.3-1991 Format and printing quality of medical and health medical examination report
  • DB31/T 60.2-1991 Naming rules and classification of inspection items in medical and health medical inspection reports

Danish Standards Foundation, regenerative medicine therapy

  • DS/CEN/CR 12587:1997 Medical Informatics - Methodology for the development of healthcare messages
  • DS/EN ISO 11737-1/AC:2009 Sterilization of medical devices – Microbiological methods – Part 1: Determination of a population of microorganisms on products
  • DS/EN ISO 11737-1:2006 Sterilization of medical devices – Microbiological methods – Part 1: Determination of a population of microorganisms on products
  • DS/EN 30993-5:1994 Biological evaluation of medical devices-Part 5:Tests for cytotoxicity-in vitro methods
  • DS/ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation
  • DS/ISO/TR 10993-22:2021 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
  • DS/ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices – Part 1: General requirements
  • DS/ISO 10993-12:2021 Biological evaluation of medical devices – Part 12: Sample preparation and reference materials
  • DS/EN ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation (ISO 10993-23:2021)
  • DS/EN 12322/A1:2002 In vitro diagnostic medical devices - Culture media for microbiology - Performance criteria for culture media
  • DS/EN 12322:1999 In vitro diagnostic medical devices - Culture media for microbiology - Performance criteria for culture media
  • DS/EN 30993-4:1994 Biological evaluation of medical devices. Part 4: Selection of tests for interactions with blood
  • DS/EN 30993-6:1995 Biological evaluation of medical devices - Part 6:Tests for local effects after implantation
  • DS/EN ISO 10993-12:2012 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • DS 2451-13:2011 Infection control in the health care sector - Part 13: Requirements for reprocessing of reusable medical equipment
  • DS 2451-13 E:2011 Infection control in the health care sector - Part 13: Requirements for reprocessing of reusable medical equipment

German Institute for Standardization, regenerative medicine therapy

  • DIN EN ISO 10993-17:2021-12 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021 / Note: Date of issue 2021-11-12*Intended as replacement for DIN...
  • DIN EN ISO 17664:2004 Sterilization of medical devices - Information to be provided by the manufacturer for the processing of resterilizable medical devices (ISO 17664:2004); German version EN ISO 17664:2004
  • DIN EN 16872:2017-02 Services of Medical Doctors with additional qualification in Homeopathy (MDQH) - Requirements for health care provision by Medical Doctors with additional qualification in Homeopathy; German version EN 16872:2016
  • DIN 58959 Bb.1:1997 Quality management in medical microbiology - Overview and index
  • DIN EN 16872:2017 Services of Medical Doctors with additional qualification in Homeopathy (MDQH) - Requirements for health care provision by Medical Doctors with additional qualification in Homeopathy
  • DIN EN ISO 10993-18:2021-03 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020); German version EN ISO 10993-18:2020 / Note: To be amended by DIN EN ISO 10993-18/A1 (2021-10).
  • DIN EN ISO 10993-10:2023-04 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021); German version EN ISO 10993-10:2023
  • DIN EN ISO 10993-2:2023-02 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022); German version EN ISO 10993-2:2022
  • DIN EN ISO 10993-11:2018-09 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017); German version EN ISO 10993-11:2018
  • DIN 58959-4:1997 Quality management in medical microbiology - Part 4: Requirements for investigations using light microscopes
  • DIN 6870-1:2009 Quality management system in medical radiology - Part 1: Radiotherapy
  • DIN EN ISO 10993-18:2023-11 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020 + Amd 1:2022); German version EN ISO 10993-18:2020 + A1:2023
  • DIN 58959-6:1997 Quality management in medical microbiology - Part 6: Requirements for control strains
  • DIN EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005); German version EN ISO 10993-18:2005
  • DIN EN ISO 10993-13:2010-11 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010); German version EN ISO 10993-13:2010
  • DIN EN ISO 10993-5:2009-10 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009); German version EN ISO 10993-5:2009
  • DIN-Fachbericht 73:1998 Medical informatics - Methodology for the development of healthcare messages - CEN-Report 12587
  • DIN 58943-8:2009 Medical microbiology - Diagnosis of tuberculosis - Part 8: Methods for the determination of susceptibility of tubercle bacilli to chemotherapeutic agents; Text in German and English
  • DIN 58962-2:1994 Medical microbiology - Diagnosis of infections of the lower respiratory tract (LRT) - Part 2: Microscopic examination
  • DIN EN 12322:1999-06 In vitro diagnostic medical devices - Culture media for microbiology - Performance criteria for culture media; German version EN 12322:1999
  • DIN EN ISO 10993-6:2017-09 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016); German version EN ISO 10993-6:2016
  • DIN EN ISO 10993-12:2021-08 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021); German version EN ISO 10993-12:2021
  • DIN 58940-1:2002 Medical microbiology - Susceptibility testing of pathogens to antimicrobial agents - Part 1: Terminology
  • DIN EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020); German version EN ISO 10993-18:2020
  • DIN EN ISO 10993-18/A1:2021-10 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021); German and English version...
  • DIN EN ISO 10993-3:2015-02 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014); German version EN ISO 10993-3:2014
  • DIN 58959-3:1997 Quality management in medical microbiology - Part 3: Requirements for request and report forms
  • DIN 58959-1:1997 Quality management in medical microbiology - Part 1: Requirements for the QM system
  • DIN EN ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2006); German version EN ISO 10993-11:2006
  • DIN EN ISO 10993-7:2009 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008); English version of DIN EN ISO 10993-7:2009-02
  • DIN EN ISO 10993-23:2021-10 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021); German version EN ISO 10993-23:2021

Standard Association of Australia (SAA), regenerative medicine therapy

Association Francaise de Normalisation, regenerative medicine therapy

  • NF EN ISO 16954:2015 Médecine bucco-dentaire - Méthodes d'essai pour le traitement du biofilm dans les conduites d'eau de l'unit dentaire
  • NF EN 16872:2016 Services de santé des docteurs en médecine ayant une qualification complémentaire en homéopathie - Exigences relatives aux prestations de soins de santé fournies par les docteurs en médecine ayant une qualification complémentaire en homéopathie
  • NF S99-803*NF EN 16872:2016 Services of medical doctors with additional qualification in homeopathy (MDQH) - Requirements for health care provision by medical doctors with additional qualification in homeopathy
  • NF S99-501:1998 Biological evaluation of medical devices. Part 1 : evaluation and testing.
  • NF S97-512*NF EN 1614:2006 Health Informatics - Representation of dedicated kinds of property laboratory medicine
  • NF S99-501-18*NF EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18 : chemical characterization of medical device materials within a risk management process
  • NF EN ISO 10993-18:2020 Évaluation biologique des dispositifs médicaux - Partie 18 : caractérisation chimique des matériaux des dispositifs médicaux au sein d'un processus de gestion du risque
  • NF S90-701:1988 MEDICO-SURGICAL EQUIPMENT. BIOCOMPATIBILITY OF MATERIALS AND MEDICAL DEVICES. METHODS FOR EXTRACTION.
  • NF S91-224:2009 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry.
  • NF EN ISO 10993-23:2021 Evaluation biologique des dispositifs médicaux - Partie 23 : essais d'irritation
  • NF S99-501-18:2009 Biological evaluation of medical devices - Part 18 : chemical characterization of materials.
  • NF EN ISO 10993-13:2010 Évaluation biologique des dispositifs médicaux - Partie 13 : identification et quantification de produits de dégradation de dispositifs médicaux à base de polymères
  • NF S98-118-1:2006 Sterilization of medical devices - Microbiological methods - Part 1 : determination of a population of microorganisms on products.
  • NF S99-501-23*NF EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23 : tests for irritation
  • NF S99-501-13*NF EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13 : identification and quantification of degradation products from polymeric medical devices
  • NF EN ISO 10993-11:2018 Évaluation biologique des dispositifs médicaux - Partie 11 : essais de toxicité systémique
  • NF EN ISO 10993-10:2023 Évaluation biologique des dispositifs médicaux - Partie 10 : essais de sensibilisation cutanée
  • NF EN ISO 13120:2019 Informatique de santé - Syntaxe de représentation du contenu des systèmes de classification des soins de santé - Langage de marquage de la classification (ClaML)
  • NF S99-518:2005 Biological evaluation of medical devices - Part 18 : chemical characterization of materials.
  • NF S99-501-11:2009 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity.
  • NF S99-501-11*NF EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity
  • NF S99-510:1996 Biological evaluation of medical devices. Part 10 : tests for irritation and sensitization.
  • FD S99-501-22*FD ISO/TR 10993-22:2017 Biological evaluation of medical devices - Part 22 : guidance on nanomaterials
  • FD ISO/TR 10993-22:2017 Évaluation biologique des dispositifs médicaux - Partie 22 : lignes directrices sur la nanomatériaux
  • NF C74-236-1*NF EN 62563-1:2010 Medical electrical equipment - Medical image display systems - Part 1 : evaluation methods.
  • FD S99-516*FD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • NF EN ISO 10993-2:2022 Évaluation biologique des dispositifs médicaux - Partie 2 : Exigences relatives à la protection des animaux
  • FD ISO/TR 37137:2014 Évaluation biologique cardiovasculaire des dispositifs médicaux - Directives pour les implants absorbables
  • NF EN ISO 10993-5:2010 Évaluation biologique des dispositifs médicaux - Partie 5 : essais concernant la cytotoxicité in vitro
  • NF EN ISO 10993-18/A1:2023 Évaluation biologique des dispositifs médicaux - Partie 18 : caractérisation chimique des matériaux des dispositifs médicaux au sein d\'un processus de gestion du risque - Amendement 1 : détermination du coefficient d\'incertitude
  • NF S99-501-5*NF EN ISO 10993-5:2010 Biological evaluation of medical devices - Part 5 : tests for in vitro cytotoxicity.
  • NF S99-507:1996 Biological evaluation of medical devices. Part 7 : ethylene oxide sterilization residuals.
  • NF EN ISO 10993-6:2017 Évaluation biologique des dispositifs médicaux - Partie 6 : essais concernant les effets locaux après implantation
  • NF EN ISO 10993-7:2008 Évaluation biologique des dispositifs médicaux - Partie 7 : résidus de stérilisation à l'oxyde d'éthylène
  • XP ISO/TS 10993-19:2022 Évaluation biologique des dispositifs médicaux - Partie 19 : caractérisations physicochimique, morphologique et topographique des matériaux
  • NF EN ISO 10993-3:2014 Évaluation biologique des dispositifs médicaux - Partie 3 : essais concernant la génotoxicité, la cancérogénicité et la toxicité sur la reproduction
  • NF S99-501-12:2012 Biological evaluation of medical devices - Part 12 : sample preparation and reference materials.
  • NF S99-501-7*NF EN ISO 10993-7:2008 Biological evaluation of medical devices - Part 7 : ethylene oxide sterilization residuals.
  • NF S99-501-12*NF EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12 : sample preparation and reference materials
  • NF S99-506:1995 Biological evaluation of medical devices. Part 6 : tests for local effects after implantation.
  • NF S99-501-10*NF EN ISO 10993-10:2013 Biological evaluation of medical devices - Part 10 : tests for irritation and skin sensitization
  • NF EN 12322/A1:2002 Dispositifs médicaux de diagnostic in vitro - Milieux de culture de microbiologie - Critères de performance des milieux de culture
  • NF EN ISO 10993-17:2009 Évaluation biologique des dispositifs médicaux - Partie 17 : établissement des limites admissibles des substances relargables
  • AFNOR SPEC S93-250:2022 Néonatalogie - Exigences relatives aux dispositifs médicaux destinés à l'administration de l'alimentation et des médicaments par voie entérale
  • NF EN 12322:1999 Dispositifs médicaux de diagnostic in vitro - Milieux de culture de microbiologie - Critères de performance des milieux de culture.
  • NF EN ISO 10993-12:2021 Evaluation biologique des dispositifs médicaux - Partie 12 : préparation des échantillons et matériaux de référence
  • NF X30-504:2013 Déchets d'activités de soins - Bonnes pratiques de collecte des déchets d'activités de soins à risques infectieux

European Committee for Standardization (CEN), regenerative medicine therapy

  • EN ISO 17664:2004 Sterilization of medical devices - Information to be provided by the manufacturer for the processing of resterilizable medical devices
  • FprEN ISO 10993-17 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/FDIS 10993-17:2023)
  • EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
  • EN ISO 7405:2018 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry (ISO 7405:2018, Corrected version 2018-12)
  • EN ISO 7405:2008 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry (ISO 7405:2008)
  • PD CEN/TS 15127-1-2005_ Health informatics - Testing of physiological measurement software - Part 1: General
  • EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • PD CEN/TS 15127-1:2005 Health informatics - Testing of physiological measurement software - Part 1: General
  • EN ISO 11737-1:2018 Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products
  • EN ISO 10993-18:2020/prA1 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • EN ISO 10993-1:1997 Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing Supersedes EN 30993-1: 1994; ISO 10993-1 : 1997
  • EN ISO 10993-1:2020 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)
  • EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • EN ISO 10993-1:2003 Biological evaluation of medical devices Part 1: Evaluation and testing ISO 10993-1:2003
  • EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:1995 Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity (ISO 10993-11 : 1993)
  • EN ISO 10993-8:2000 Biological Evaluation of Medical Devices - Part 8: Selection and Qualification of Reference Materials for Biological Tests ISO 10993-8:2000
  • EN ISO 11737-1:2018/A1:2021 Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products - Amendment 1 (ISO 11737-1:2018/Amd 1:2021)
  • EN ISO 10993-18:2020/prA1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021)
  • EN ISO 7405:2008/A1:2013 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry - Amendment 1: Positive control material (ISO 7405:2008/Amd 1:2013)
  • EN 15354:2022 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • EN 12929-2:2015+A1:2022 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)

International Organization for Standardization (ISO), regenerative medicine therapy

  • ISO/TS 10993-20:2006 Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices
  • ISO 7405:2008 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry
  • ISO 7405:2018 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry
  • ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ISO 11737-1:2006 Sterilization of medical devices - Microbiological methods - Part 1: Determination of a population of microorganisms on products
  • ISO 11737-1:1995 Sterilization of medical devices - Microbiological methods - Part 1: Estimation of population of microorganisms on products
  • ISO/TR 15499:2016 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-13:1998 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO/TS 21726:2019 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • ISO 10993-5:1992 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-1:2003 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • ISO 10993-2:2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • ISO 10993-2:1992 Biological evaluation of medical devices; part 2: animal welfare requirements
  • ISO 10993-11:1993 Biological evaluation of medical devices; part 11: tests for systemic toxicity
  • ISO 10993-10:1995 Biological evaluation of medical devices - Part 10: Tests for irritation and sensitization
  • ISO 10993-2:2022 Biological evaluation of medical devices — Part 2: Animal welfare requirements
  • ISO/TR 10993-22:2017 Biological evaluation of medical devices — Part 22: Guidance on nanomaterials
  • ISO 10993-10:2021 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • ISO 11737-3:2004 Sterilization of medical devices - Microbiological methods - Part 3: Guidance on evaluation and interpretation of bioburden data
  • ISO 10993-8:2000 Biological evaluation of medical devices - Part 8: Selection and qualification of reference materials for biological tests
  • ISO/TR 15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices — Part 1: General requirements
  • ISO/TS 10993-19:2006 Biological evaluation of medical devices - Part 19: Physico-chemical, morphological and topographical characterization of materials
  • ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • ISO 10993-11:2017 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO/TS 11796:2023 Biological evaluation of medical devices — Requirements for interlaboratory studies to demonstrate the applicability of validated in vitro methods to assess the skin sensitization of medical devices
  • ISO 10993-18:2020 Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process — Amendment 1: Determination of the uncertainty factor
  • ISO 10993-12:2007 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • ISO 10993-6:1994 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • ISO 10993-7:1995 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-7:2008 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-12:2021 Biological evaluation of medical devices — Part 12: Sample preparation and reference materials
  • ISO 10993-12:2012 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials

AENOR, regenerative medicine therapy

  • UNE-ENV 12388:1997 MEDICAL INFORMATICS. ALGORITHM FOR DIGITAL SIGNATURE SERVICES IN HEALTH CARE.
  • UNE-EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • UNE-EN ISO 11737-1:2007 Sterilization of medical devices - Microbiological methods - Part 1: Determination of a population of microorganisms on products (ISO 11737-1:2006)
  • UNE-EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
  • UNE 111912:1990 PROTHECTICS AND ORTHOTICS. MEDICAL ASPECTS. DECRIPTION OF LIMB DEFICIENCIES PRESENT AT BIRTH

ES-UNE, regenerative medicine therapy

  • UNE-EN 16872:2016 Services of Medical Doctors with additional qualification in Homeopathy (MDQH) - Requirements for health care provision by Medical Doctors with additional qualification in Homeopathy (Endorsed by AENOR in December of 2016.)
  • UNE-EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • UNE-EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • UNE-EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
  • UNE-EN ISO 10993-12:2022 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • UNE-EN ISO 10993-2:2023 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • UNE-EN ISO 10993-10:2023 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021)

North Atlantic Treaty Organization Standards Agency, regenerative medicine therapy

  • STANAG 2478-2006 MEDICAL SUPPORT PLANNING FOR NUCLEAR, BIOLOGICAL AND CHEMICAL ENVIRONMENTS
  • STANAG 2873-2007 CONCEPT OF OPERATIONS OF MEDICAL SUPPORT IN CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR ENVIRONMENTS - AMedP-7(D)

国家药监局, regenerative medicine therapy

  • YY/T 1636-2018 In vivo magnetic resonance evaluation method for tissue engineering medical device products to regenerate knee joint cartilage
  • YY/T 1737-2020 Analytical methods for bioburden control levels of medical devices

IT-UNI, regenerative medicine therapy

  • UNI EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process
  • UNI EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • UNI EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials

KR-KS, regenerative medicine therapy

  • KS P ISO 10993-18-2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process
  • KS P ISO 10993-13-2018 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
  • KS P ISO 10993-1-2020 Biological evaluation of medical devices —Part 1: Evaluation and testing within a risk management process
  • KS P ISO 10993-23-2022 Biological evaluation of medical devices — Part 23: Tests for irritation
  • KS P ISO 10993-11-2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO TR 10993-22-2020 Biological evaluation of medical devices —Part 22: Guidance on nanomaterials
  • KS P ISO 10993-10-2022 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • KS C IEC 62563-1-2019 Medical electrical equipment — Medical image display systems — Part 1: Evaluation methods
  • KS P ISO 10993-8-2002 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-5-2018 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
  • KS P ISO 10993-7-2017 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO TR 37137-2019 Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants
  • KS P ISO 10993-10-2018 Biological evaluation of medical devices — Part 10: Tests for irritation and skin sensitization
  • KS P ISO 10993-7-2022 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals

VN-TCVN, regenerative medicine therapy

  • TCVN 7391-18-2007 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • TCVN 7391-1-2004 Biological evaluation of medical devices.Part 1: Evaluation and testing
  • TCVN 7391-2-2005 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • TCVN 7391-11-2007 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • TCVN 7391-5-2005 Biological evaluation of medical devices.Part 5: Tests for in vitro cytotoxicity
  • TCVN 7391-12-2007 Biological evaluation of medical devices.Part 12: Sample preparation and reference materials
  • TCVN 7391-6-2007 Biological evaluation of medical devices.Part 6: Tests for local effects after implantation
  • TCVN 7391-7-2004 Biological evaluation of medial devices.Part 7: Etylen oxide sterilization residuals
  • TCVN 7391-3-2005 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity

TH-TISI, regenerative medicine therapy

  • TIS 2395.18-2008 Biological evaluation of medical devices.part 18: chemical characterization of materials
  • TIS 2395.13-2008 Biological evaluation of medical devices.part 13: identification and quantification of degradation products from polymeric medical devices
  • TIS 2395.1-2008 Biological evaluation of medical devices.part 1: evaluation and testing
  • TIS 2395.11-2008 Biological evaluation of medical devices.part 11: tests for systemic toxicity
  • TIS 2279.3-2006 Sterilization of medical devices.microbiological methods.part 3: guidance on evaluation and interpretation of bioburden data
  • TIS 2395.2-2008 Biological evaluation of medical devices.part 2: animal welfare requirements
  • TIS 2395.5-2008 Biological evaluation of medical devices.part 5: tests for in vitro cytotoxicity
  • TIS 2395.6-2008 Biological evaluation of medical devices.part 6: tests for local effects after implantation
  • TIS 2395.7-2008 Biological evaluation of medical devices.part 7: ethylene oxide sterilization residuals
  • TIS 2395.12-2008 Biological evaluation of medical devices.part 12: sample preparation and reference materials
  • TIS 2395.3-2008 Biological evaluation of medical devices.part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity

Institute of Electrical and Electronics Engineers (IEEE), regenerative medicine therapy

SE-SIS, regenerative medicine therapy

Group Standards of the People's Republic of China, regenerative medicine therapy

  • T/CAMDI 033-2020 Guide for biological evaluation of packaging materials for medical devices
  • T/CSBM 0029-2022 Standard guide for in vivo assessment of implantable devices intended to repair or regenerate articular cartilage
  • T/CAMDI 034-2020 Biological evaluation of medical devices Medical catheter with hydrophilic polymer coating:Sample preparation
  • T/ZJSES 001-2023 Polyester Chemical Recycling Engineering Resin Raw Materials

CEN - European Committee for Standardization, regenerative medicine therapy

  • EN ISO 10993-13:2009 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • EN ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-6:2009 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • EN ISO 10993-6:2007 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation

CZ-CSN, regenerative medicine therapy

  • CSN 84 7106-1983 Medlcal eguipment. Methods, means and processes of sterllization and desinfection of items for medical use. Terms and definitions.

国家食品药品监督管理局, regenerative medicine therapy

  • YY/T 1532-2017 Medical device biological evaluation nanomaterials hemolysis test
  • YY/T 1512-2017 Implementation Guidelines for Biological Evaluation in the Risk Management Process of Biological Evaluation of Medical Devices
  • YY/T 1535-2017 Biological evaluation of medical devices for human in vitro assisted reproductive technology and human sperm survival test
  • YY/T 0127.13-2018 Biological evaluation of oral medical devices Part 13: Oral mucosal irritation test

European Committee for Electrotechnical Standardization(CENELEC), regenerative medicine therapy

  • prEN IEC 63120:2021 Refurbishment of medical electrical equipment, medical electrical systems and sub-assemblies and reuse of components as part of the extended life-cycle

中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会, regenerative medicine therapy

  • GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices
  • GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization
  • GB/T 16886.12-2017 Biological evaluation of medical devices—Part 12:Sample preparation and reference materials

AT-ON, regenerative medicine therapy

  • OENORM EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • OENORM EN ISO 10993-18/A1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020/DAM 1:2021) (Amendment)
  • ONORM K 2020 Teil.2-1981 Freeze-drying of substances of biological origin for medical use; methods

CH-SNV, regenerative medicine therapy

  • SN EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • SN EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)

PL-PKN, regenerative medicine therapy

  • PN-EN ISO 10993-18-2020-11 E Biological evaluation of medical devices -- Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • PN-EN ISO 10993-23-2021-08 E Biological evaluation of medical devices -- Part 23: Tests for irritation (ISO 10993-23:2021)

ZA-SANS, regenerative medicine therapy

  • SANS 10993-1:2003 Biological evaluation of medical devices Part 1: Evaluation and testing
  • SANS 10993-5:2003 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity

NATO - North Atlantic Treaty Organization, regenerative medicine therapy

  • AMEDP-7(D)-2007 CONCEPT OF OPERATIONSOF MEDICAL SUPPORT INCHEMICAL BIOLOGICAL RADIOLOGICAL AND NUCLEAR ENVIRONMENTS

Japanese Industrial Standards Committee (JISC), regenerative medicine therapy

  • JIS T 0993-1:2005 Biological evaluation of medical devices -- Part 1: Evaluation and testing
  • JIS T 11737-1:2013 Sterilization of medical devices.Microbiological methods.Part 1: Determination of a population of microorganisms on products
  • JIS G 0580:1986 Method of electrochemical potentiokinetic reactivation ratio measurement for stainless steels
  • JIS T 0993-7:2012 Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals

国家市场监督管理总局、中国国家标准化管理委员会, regenerative medicine therapy

  • GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity
  • GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation
  • GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity

National Fire Protection Association (NFPA), regenerative medicine therapy

US-AAMI, regenerative medicine therapy

IN-BIS, regenerative medicine therapy

PH-BPS, regenerative medicine therapy

  • PNS ISO 10993-11:2021 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • PNS ISO 10993-2:2021 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • PNS ISO 10993-5:2021 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • PNS ISO 10993-10:2021 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization
  • PNS ISO 10993-7:2021 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals

American National Standards Institute (ANSI), regenerative medicine therapy

International Electrotechnical Commission (IEC), regenerative medicine therapy

  • IEC 62563-1:2009 Medical electrical equipment - Medical image display systems - Part 1: Evaluation methods

Lithuanian Standards Office , regenerative medicine therapy

  • LST EN ISO 11737-1:2006 Sterilization of medical devices - Microbiological methods - Part 1: Determination of a population of microorganisms on products (ISO 11737-1:2006)
  • LST EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • LST EN 12322-2000 In vitro diagnostic medical devices - Culture media for microbiology - Performance criteria for culture media
  • LST EN ISO 11737-1:2006/AC:2009 Sterilization of medical devices - Microbiological methods - Part 1: Determination of a population of microorganisms on products (ISO 11737-1:2006/Cor 1:2007)

RO-ASRO, regenerative medicine therapy

  • STAS SR EN 30993-1-1996 Biological evaluation of medical devices -Part 1: Guidance on selection of tests
  • STAS SR EN 30993-5-1996 Biological evaluation of medical devices -Part 5: Tests for cytotoxicity: in vitro methods
  • STAS SR EN 30993-3-1996 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenity and reproductive toxicity

Professional Standard - Public Safety Standards, regenerative medicine therapy

AT-OVE/ON, regenerative medicine therapy

  • OVE EN IEC 63120:2021 Refurbishment of medical electrical equipment, medical electrical systems and sub-assemblies and reuse of components as part of the extended life-cycle (IEC 62A/1424/CDV) (english version)

IEEE - The Institute of Electrical and Electronics Engineers@ Inc., regenerative medicine therapy

IX-EU/EC, regenerative medicine therapy

  • 84/539/EEC-1984 Council Directive on the Approximation of the Laws of the Member States Relating to Electro-Medical Equipment Used in Human or Veterinary Medicine

PT-IPQ, regenerative medicine therapy

  • NP EN 1174-3-2000 Sterilization of medical devices Estimation of the population of micro-organisms on product Part 3:Guide to the methods for validation of microbiological techniques




Copyright ©2007-2023 ANTPEDIA, All Rights Reserved